Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Eliacik E"'
Publikováno v:
International Medical Case Reports Journal, Vol 2016, Iss Issue 1, Pp 61-64 (2016)
Umit Yavuz Malkan, Gursel Gunes, Eylem Eliacik, Ibrahim Celalettin Haznedaroglu Department of Hematology, School of Medicine, Hacettepe University, Ankara, Turkey Abstract: Thalidomide may be used as a treatment option for pyoderma gangrenosum (PG) a
Externí odkaz:
https://doaj.org/article/5e95474825d446d2b3077b21d0e048c5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Uz, B., Bektas, O., Eliacik, E., Goker, H., Erbilgin, Y., Sayitoglu, M., Sayinalp, N., Aksu, S., Buyukasik, Y., Ozcebe, O., Haznedaroglu, I. C.
Publikováno v:
Case Reports in Hematology.
The current treatment of chronic phase chronic myeloid leukemia (CML) consists of oral tyrosine kinase inhibitors (TKIs). However, high-risk CML may present with an aggressive course which may result in blastic crisis or a “difficult-to-manage” s
Autor:
Malkan, Ü.Y., Günes, G., Eliaçık, E., Işık, A., Sayinalp, N., Aksu, S., Göker, H., Demiroğlu, H.
Publikováno v:
In Leukemia Research 15 October 2014 38 Supplement 1:S47-S47
Autor:
Malkan, Ü.Y., Güneş, G., Eliaçık, E., Işık, A., Sayınalp, N., Göker, H., Demiroğlu, H., Aksu, S., Büyükaşık, Y., Haznedaroğlu, İ.C.
Publikováno v:
In Leukemia Research 15 October 2014 38 Supplement 1:S45-S46
PP-058 MYASTENIA GRAVIS AND WALDENSTROM MACROGLOBULINEMIA: IS COMMON IMMUNOLOGIC MECHANISM POSSIBLE?
Autor:
Malkan, Ü.Y., Güneş, G., Işık, A., Eliaçık, E., Sayınalp, N., Demiroğlu, H., Göker, H., Haznedaroğlu, İ.
Publikováno v:
In Leukemia Research 15 October 2014 38 Supplement 1:S46-S46
Autor:
Malkan, Ü.Y., Güneş, G., Okay, M., Eliaçık, E., Işık, A., Sayinalp, N., Göker, H., Özcebe, O.İ., Demiroğlu, H.
Publikováno v:
In Leukemia Research 15 October 2014 38 Supplement 1:S45-S45
Publikováno v:
In Leukemia Research 15 October 2014 38 Supplement 1:S40-S40
Publikováno v:
In Leukemia Research 15 October 2014 38 Supplement 1:S41-S41